Adverum Biotechnologies, Inc. Variable Lease, Cost
Adverum Biotechnologies, Inc. reported Variable Lease, Cost of $2.30 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-04-15
- Adverum Biotechnologies, Inc. variable lease, cost for the quarter ending 2021-12-31 was $500.00K, a 25.00% increase year-over-year.
- Adverum Biotechnologies, Inc. variable lease, cost for the quarter ending 2021-09-30 was $600.00K, a 50.00% increase year-over-year.
- Adverum Biotechnologies, Inc. variable lease, cost for the quarter ending 2020-12-31 was $400.00K, a 42.86% decline year-over-year.
- Adverum Biotechnologies, Inc. variable lease, cost for the quarter ending 2020-09-30 was $400.00K, a 0.00% change year-over-year.
- Adverum Biotechnologies, Inc. variable lease, cost for fiscal 2024 was $2.30M, a 4.17% decline from fiscal 2023.
- Adverum Biotechnologies, Inc. variable lease, cost for fiscal 2023 was $2.40M, a 4.35% increase from fiscal 2022.
- Adverum Biotechnologies, Inc. variable lease, cost for fiscal 2022 was $2.30M, a 27.78% increase from fiscal 2021.
- Adverum Biotechnologies, Inc. variable lease, cost for fiscal 2021 was $1.80M, a 20.00% increase from fiscal 2020.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.30M 10-K · filed 2025-04-15 | |||
| 2023-12-31 | $2.40M 10-K · filed 2025-04-15 | |||
| 2022-12-31 | $2.30M 10-K · filed 2024-03-18 | |||
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.10M derived: sum of 2 quarters · filed 2023-03-30 | $1.80M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $600.00K 10-Q · filed 2021-11-04 | $1.30M 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $700.00K 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $800.00K derived: sum of 2 quarters · filed 2022-03-29 | $1.50M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $400.00K 10-Q · filed 2021-11-04 | $1.10M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $800.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.10M derived: sum of 2 quarters · filed 2021-03-01 | $1.40M derived: sum of 3 quarters · filed 2021-03-01 | $1.60M 10-K · filed 2021-03-01 |
| 2019-09-30 | $400.00K 10-Q · filed 2019-11-07 | $700.00K derived: sum of 2 quarters · filed 2019-11-07 | $900.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $300.00K 10-Q · filed 2019-08-08 | $500.00K 10-Q · filed 2019-08-08 | ||
| 2018-09-30 | $200.00K 10-Q · filed 2019-11-07 | $400.00K derived: sum of 2 quarters · filed 2019-11-07 | $700.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-08 | $500.00K 10-Q · filed 2019-08-08 |